InvestorsHub Logo
icon url

Evaluate

09/10/14 6:41 PM

#18562 RE: rrflyboy #18552

RRFlyBoy ... I agree with you, and I have also been frustrated by my NWBO options going down in value due to things not happening within expected/anticipated timeline (ie 1st interim efficacy, big news at ASCO, big news about initial results on Direct, imminent news regarding Hospital Reimbursement etc in Germany). I recognize that the company has been making good progress on various fronts, and that the stock has not been rising as hoped for in part due to Feuerstein and the Buzdar situation, but also due to the trial enhancements related to low CD4 etc. One thing you might try is calling Les Goldman to discuss any questions you might have ... I agree with other posters that this appears to be a better way to get a reply/response than sending an email.
icon url

lunatick

09/10/14 7:30 PM

#18565 RE: rrflyboy #18552

Hi rrflyboy,
I think Linda Powers can't know the exact date of authorization for reimbursement of medical expenses by the statutory health insurance in Germany. The hospitals submit the applications. Applications for reimbursement must be submitted until October 31, 2014, for the following year (2015). If my guess is right, there will be no statutory regulation for a refund for the year 2014. But and this is important, this does not mean that hospitals can get no money for treatment.
As I understand it, the hospitals have the opportunity to negotiate direktly with health insurance companies. But further applications shall be lodged and this takes time.
In Germany there are several health insurance, some are private and some are required by law. On the Internet I could find three older patient reports in which it is mentioned, that teir private health insurance has paid immunotherapy. So far, the legal insurance companies have taken no cost for immunotherapy with dendric cells, but this will change.
Above all it is interesting that 10 hospitals have submitted applications, that means that they want to start the treatment with DCVax-L and that they have patients who want this treatment.
I think we need to be patient